AERPIO PHARMACEUTICALS INC's ticker is ARPO and the CUSIP is 00810B105. A total of 19 filers reported holding AERPIO PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2020 | $46,000 | +39.4% | 35,500 | -41.8% | 0.00% | – |
Q1 2020 | $33,000 | -15.4% | 61,000 | 0.0% | 0.00% | – |
Q4 2019 | $39,000 | +77.3% | 61,000 | +77.1% | 0.00% | – |
Q3 2019 | $22,000 | -33.3% | 34,450 | -8.0% | 0.00% | – |
Q2 2019 | $33,000 | +17.9% | 37,450 | +15.4% | 0.00% | – |
Q1 2019 | $28,000 | -34.9% | 32,450 | +27.5% | 0.00% | – |
Q4 2018 | $43,000 | +10.3% | 25,450 | +96.5% | 0.00% | – |
Q3 2018 | $39,000 | -25.0% | 12,950 | +3.6% | 0.00% | – |
Q2 2018 | $52,000 | – | 12,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
NEVILLE RODIE & SHAW INC | 100,000 | $475,000 | 0.05% |